Trials / Recruiting
RecruitingNCT04114435
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants: A Prospective Cross-sectional Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
- Sex
- All
- Age
- 7 Days – 5 Years
- Healthy volunteers
- Accepted
Summary
Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study
Detailed description
The principal investigator hypothesize that premature newborns have disturbed cardiac performance and increased pulmonary pressures during neonatal life and at different pediatric ages. The principal investigator also hypothesize that premature newborns with poor cardiac performance and/or pulmonary hypertension have higher morbidities and poorer neuro-developmental outcomes. The principal investigator also hypothesize that premature newborns with poor cardiac performance and/or pulmonary hypertension have higher morbidities and poorer neuro-developmental outcomes and that novel echocardiography techniques will detect anomalies not uncovered by conventional imaging, and that early echocardiography may identify those with later pulmonary hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Echocardiography | Diagnostic test which uses ultrasound waves to make images of the heart chambers, valves and surrounding structures |
Timeline
- Start date
- 2019-10-12
- Primary completion
- 2023-11-30
- Completion
- 2025-12-01
- First posted
- 2019-10-03
- Last updated
- 2025-06-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04114435. Inclusion in this directory is not an endorsement.